Proteome profiling of enzalutamide-resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration-resistant prostate cancer.
Journal Information
Full Title: Int J Cancer
Abbreviation: Int J Cancer
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data availability statement the raw mass spectrometry data generated in this study have been deposited in the pride database with accession number pxd031847 ( http://www ebi ac uk/pride )."
"CONFLICT OF INTEREST Boris Hadaschik reported consulting fees from Bayer, Janssen, Novartis, BMS, AstraZeneca, MSD, Pfizer, Amgen and Astellas. The other authors declare no potential conflicts of interest."
"Funding information János Bolyai Research Scholarship of the Hungarian Academy of Sciences; National Research, Development and Innovation Office, Grant/Award Number: NKFIH/FK 124431; New National Excellence Program of the Ministry for Innovation and Technology, Grant/Award Numbers: ÚNKP‐21‐3‐II‐SE‐13, ÚNKP‐21‐5‐SE‐3; Protein Research Unit Ruhr within Europe, Ministry of Innovation, Science and Research of North‐Rhine Westphalia, Germany"
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025